Ropes & Gray grows FDA practice

08 Jul 2002
News

Executive Summary

Bennett, Turner & Coleman D.C. law firm will merge into Ropes & Gray's Health and Life Sciences Practices. Ropes & Gray, which employs two attorneys in its FDA practice, will gain BT&C's 11 attorneys with expertise in FDA regulatory issues. During a House Commerce/Oversight Subcommittee hearing on ImClone's Erbitux, a Bristol exec testified that Bennett, Turner & Coleman partner Alan Bennett informed him that a refuse-to-file letter from FDA was imminent (1"The Pink Sheet" June 17, p. 5)...

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS040134

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS040134

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Ropes &amp; Gray grows FDA practice

News

Executive Summary

Related Content

Erbitux Hearing Puts Focus On Pre-Approval Promotion, FDA Communication

Erbitux Hearing Puts Focus On Pre-Approval Promotion, FDA Communication

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert

Ropes & Gray grows FDA practice